NCT01605942

A Safety and Efficacy Study of a Dexamethasone Drug Delivery System for Postoperative Inflammation and Pain After Cataract Surgery

• Status: Terminated
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 8 (actual)
• Sponsor: Allergan · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is a safety and efficacy study of a Dexamethasone Drug Delivery System for anterior segment inflammation and pain following cataract extraction with lens implantation.

Conditions

• Cataract

Interventions

Type	Name	Description
DRUG	Dexamethasone Drug Delivery System	Dexamethasone Drug Delivery System administered into the study eye at the conclusion of cataract surgery on Day 1.
DRUG	Placebo Drug Delivery System	Placebo Drug Delivery System administered into the study eye at the conclusion of cataract surgery on Day 1.

Timeline

• Start date: 2012-06-01
• Primary completion: 2012-09-01
• Completion: 2012-09-01
• First posted: 2012-05-25
• Last updated: 2015-07-01
• Results posted: 2015-07-01

Locations

1 site across 1 country: United States